Nippon Life Global Investors Americas Inc. Cuts Holdings in Cardinal Health, Inc. $CAH

Nippon Life Global Investors Americas Inc. cut its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 15.6% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 176,890 shares of the company’s stock after selling 32,590 shares during the quarter. Cardinal Health comprises approximately 1.2% of Nippon Life Global Investors Americas Inc.’s portfolio, making the stock its 29th largest holding. Nippon Life Global Investors Americas Inc.’s holdings in Cardinal Health were worth $27,765,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently bought and sold shares of CAH. Geode Capital Management LLC lifted its position in Cardinal Health by 3.3% during the second quarter. Geode Capital Management LLC now owns 6,389,049 shares of the company’s stock valued at $1,069,005,000 after purchasing an additional 205,539 shares during the period. Norges Bank bought a new stake in Cardinal Health in the 2nd quarter worth approximately $584,420,000. Invesco Ltd. raised its stake in Cardinal Health by 7.3% during the 2nd quarter. Invesco Ltd. now owns 3,037,782 shares of the company’s stock valued at $510,347,000 after buying an additional 207,750 shares during the last quarter. Legal & General Group Plc increased its position in shares of Cardinal Health by 2.0% during the 2nd quarter. Legal & General Group Plc now owns 2,349,767 shares of the company’s stock valued at $394,761,000 after purchasing an additional 45,812 shares during the last quarter. Finally, Marshall Wace LLP lifted its stake in shares of Cardinal Health by 19.1% in the 2nd quarter. Marshall Wace LLP now owns 1,930,967 shares of the company’s stock worth $324,402,000 after purchasing an additional 309,335 shares during the period. 87.17% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on CAH. Barclays started coverage on shares of Cardinal Health in a research report on Monday, December 8th. They set an “overweight” rating and a $243.00 price objective for the company. Citigroup raised Cardinal Health from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $190.00 to $244.00 in a research note on Friday, January 9th. Leerink Partners set a $240.00 price target on shares of Cardinal Health in a research report on Tuesday. Mizuho set a $222.00 target price on shares of Cardinal Health in a research note on Monday, January 12th. Finally, Robert W. Baird set a $250.00 price target on Cardinal Health in a report on Wednesday. Fourteen investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $216.33.

Cardinal Health Stock Performance

Shares of CAH opened at $212.44 on Friday. The stock has a market capitalization of $50.48 billion, a PE ratio of 32.04, a P/E/G ratio of 1.48 and a beta of 0.65. The company’s fifty day moving average is $205.37 and its 200 day moving average is $174.71. Cardinal Health, Inc. has a fifty-two week low of $120.72 and a fifty-two week high of $215.48.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, October 30th. The company reported $2.55 EPS for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. The business had revenue of $64.01 billion during the quarter, compared to analysts’ expectations of $59.41 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The business’s revenue was up 22.4% on a year-over-year basis. During the same period last year, the company posted $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, research analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd were paid a $0.5107 dividend. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend was Friday, January 2nd. Cardinal Health’s dividend payout ratio (DPR) is presently 30.77%.

Key Stories Impacting Cardinal Health

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Recent earnings and guidance support continued upside — Cardinal beat EPS and revenue last quarter and set FY‑2026 guidance of $9.65–$9.85, which underpins bullish analyst commentary and sentiment.
• Positive Sentiment: Analyst upgrade and higher price target — Wells Fargo raised its price target to $237 and kept an “overweight” rating, signaling institutional confidence and an ~11.6% upside vs. current levels. Wells Fargo raises PT to $237
• Positive Sentiment: Momentum: 52-week high and positive coverage — Zacks notes CAH reached a 52‑week high and highlights fundamentals that could sustain the run, supporting momentum traders. Cardinal Health Hit a 52 Week High
• Neutral Sentiment: Income/dividend profile noted — A TalkMarkets dividend analysis flags CAH as a major distributor with dividend appeal for income investors, but it’s not a near-term price catalyst. Dividend Stock Analysis: Cardinal Health, Inc.
• Neutral Sentiment: Multiple Zacks pieces highlight CAH for earnings-beat potential and strong interest coverage — useful context for investors but not an immediate trigger. Will Cardinal Beat Estimates Again?
• Neutral Sentiment: General market/quote pages note price action — coverage from Globe and Mail and Economic Times provides market/quote context but no new company developments. Analysts Offer Insights on Healthcare Companies
• Negative Sentiment: Profit-taking and valuation concerns pushing a pullback — after the 52‑week high and analyst hype, investors appear to be trimming positions; intraday volume is below average and the stock carries a relatively rich P/E (~32) and other metrics (negative trailing ROE) that may prompt caution.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.